Metabolism 3.1 Energy Production from Carbohydrates (3)

Learning outcomes (Lecture Outline & Goals)
  • Roles of the TCA cycle

    • Describe its function in metabolism.

  • Regulation of the TCA cycle

    • Explain how it is controlled.

  • Key features of oxidative phosphorylation

    • Describe its characteristics.

  • Electron transport and ATP synthesis

    • Explain these processes and their coupling.

  • Uncoupling of these processes

    • Describe when, why, and how uncoupling occurs in some tissues.

  • Comparison of oxidative phosphorylation and substrate-level phosphorylation

    • Distinguish between these two mechanisms.

Quick recap: key molecules in cellular energy status
  • Adenosine Triphosphate (ATP)

    • Energy source for cellular use and storage; a nucleoside triphosphate with high-energy bonds.

  • ATP:ADP or ATP:AMP ratios

    • Regulate many metabolic activities.

  • AMP-activated protein kinase (AMPK)

    • Energy sensor that maintains cellular energy homeostasis.

  • cAMP

    • A second messenger signalling molecule.

  • Adenosine

    • Acts as a hormone/neurotransmitter.

Last week’s learning context
  • Pentose phosphate pathway, glycolysis, and intermediates linking to carbohydrate metabolism

    • Key intermediates include G-6-P, G-1-P, G-3-P, F-6-P, 5C sugar phosphates, pyruvate, lactate; glycogen involvement; connection to glycolysis.

Pyruvate Dehydrogenase (PDH) and its regulation
  • Pyruvate fate after glycolysis

    • Pyruvate, the end product of glycolysis, is transported from the cytosol to mitochondria.

    • It is converted to acetyl-CoA via the Pyruvate Dehydrogenase (PDH) complex.

    • PDH is located in the mitochondrial matrix, converting 3-carbon pyruvate to 2-carbon acetyl-CoA with CO2 release and NADH generation.

  • PDH structure and cofactors

    • PDH complex is a large multi-enzyme complex comprising 3 enzymes and several cofactors.

    • Cofactors required: thiamine pyrophosphate (TPP), FAD, NAD+, CoA, and lipoic acid.

    • Vitamin B-family factors are essential, making PDH sensitive to B-vitamin deficiencies.

  • PDH-catalysed reaction (overall)

    • The reaction (per acetyl-CoA formed) is: ext{pyruvate} + ext{CoA} + ext{NAD}^+ \ ightarrow ext{acetyl–CoA} + ext{CO}_2 + ext{NADH} + ext{H}^+

    • Stoichiometry: Pyruvate (3C) → Acetyl-CoA (2C) + CO2 + NADH.

  • PDH regulation (control by phosphorylation state and energy signals)

    • Activators: pyruvate, CoA, NAD+, ADP; insulin (via activating PDH phosphatase, promotes dephosphorylation and activation).

    • Inhibitors: acetyl-CoA, NADH, ATP, fatty acids.

    • Phosphorylation state controls activity: PDH kinase phosphorylates and inhibits PDH; PDH phosphatase dephosphorylates and activates PDH.

  • PDH deficiency (clinical)

    • A rare X-linked defect, it is the most common cause of congenital lactic acidosis.

    • Consequence: no acetyl-CoA formation and limited aerobic energy production; pyruvate accumulates and is reduced to lactate anaerobically.

    • Clinical presentation: neurological and muscular abnormalities; may be fatal in the neonatal period.

    • Management: dietary restriction of carbohydrates and proteins, ketogenic diet, and vitamin B supplementation.

    • Notably more common in men due to X-linked inheritance.

The TCA Cycle (Stage 3) and its Regulation
  • Overview and role

    • Central pathway in intracellular catabolism, occurring in mitochondria.

    • It is oxidative and exergonic, oxidizing 2 acetyl-CoA (2 C each) to 4 CO2.

    • Produces reducing equivalents: 6 NADH + H+ and 2 FADH2; 2 GTP (ATP) synthesized per glucose (two turns of the cycle per glucose).

    • Oxygen is required; intermediates serve as precursors for biosynthetic pathways.

  • Stoichiometry per acetyl-CoA (one turn)

    • Overall per cycle (one acetyl-CoA): ext{CH}3 ext{CO–S–CoA} + 3 ext{NAD}^+ + ext{FAD} + ext{GDP} + ext{P}i + 2 ext{H}2 ext{O} \ ightarrow 2 ext{CO}2 + ext{CoA} + 3 ext{NADH}^+ + ext{H}^+ + ext{FADH}_2 + ext{GTP}

    • Since 2 acetyl-CoA are formed per glucose, the total cycle outcome is doubled: 6 NADH, 2 FADH2, 2 GTP per glucose (before releasing reducing equivalents to the ETC).

  • Energy yield and substrate-level phosphorylation

    • 2 cycles per glucose → 2 GTP (substrate-level phosphorylation) per glucose.

  • Regulation of the TCA cycle (key enzymes and regulatory signals)

    • Citrate synthase (Reaction 1): Activated by acetyl-CoA; inhibited by citrate.

    • Isocitrate dehydrogenase (Reaction 4): Activated by ADP; inhibited by ATP and NADH.

    • α-ketoglutarate dehydrogenase (Reaction 5): Activated by ADP; inhibited by ATP, NADH, succinyl-CoA.

  • Biosynthetic role of TCA intermediates

    • Citrate/isocitrate/aconitate provide precursors for fatty acid synthesis and other lipids.

    • α-Ketoglutarate: amino acid synthesis and transamination reactions.

    • Succinyl-CoA: heme synthesis.

    • Oxaloacetate: gluconeogenesis (in liver) and amino acid synthesis; malate supports malate–aspartate shuttle and gluconeogenesis.

    • Overall, TCA integrates energy production with biosynthesis.

  • Summary view of the TCA cycle (key points)

    • Central hub linking carbohydrate, fat (via acetyl-CoA), and protein metabolism.

    • Occurs in mitochondria; oxidative, producing NADH and FADH2 for ATP generation via oxidative phosphorylation.

    • Produces 2 GTP (ATP equivalents) per glucose via substrate-level phosphorylation; 6 NADH and 2 FADH2 for oxidative phosphorylation.

    • Intermediates are siphoned off for biosynthesis as needed.

Oxidative Phosphorylation (Stage 4): Electron Transport and ATP Synthesis
  • Core concept

    • Electrons from NADH and FADH2 are transferred through a chain of protein complexes (ETC) to O2, releasing free energy in steps.

    • This energy is used to pump protons across the inner mitochondrial membrane, creating a proton gradient (proton-motive force, pmf).

    • The pmf drives ATP synthesis via ATP synthase (F1F0-ATPase), coupling electron transport to ATP production.

  • Electron transport chain (ETC) architecture

    • Complex I (NADH dehydrogenase): transfers electrons from NADH to ubiquinone; pumps protons.

    • Complex II (succinate dehydrogenase): transfers electrons from FADH2 to ubiquinone; does not pump protons.

    • Complex III (cytochrome bc1 complex): transfers electrons to cytochrome c; proton pumping occurs.

    • Complex IV (cytochrome c oxidase): transfers electrons to O2, forming water; pumps protons.

    • The reduced carrier (NADH or FADH2) donates electrons to the chain; oxidized carriers are regenerated.

  • Proton gradient and ATP synthase

    • Proton translocation across the inner membrane creates a proton-motive force (pmf).

    • ATP synthase uses the energy of proton flow back into the matrix to convert ADP + Pi into ATP.

    • Stoichiometry: approximately 2.5 ATP per NADH and ~1.5 ATP per FADH2 (depending on conditions and coupling efficiency).

    • The energy stored in pmf is partly converted to ATP and partly dissipated as heat in some tissues.

  • Energetics and ATP yield from NADH and FADH2

    • NADH oxidation to O2 yields ~\Delta G^\theta = -220\frac{\text{kJ}}{\text{mol}} and produces ~2.5 ATP.

    • FADH2 oxidation to O2 yields ~\Delta G^\theta = -152\frac{\text{kJ}}{\text{mol}} and produces ~1.5 ATP.

    • In glycolysis, PDH, and the TCA cycle, the total reducing equivalents (per glucose) are 10 NADH and 2 FADH2.

    • Overall energy flow: only a portion of the energy from NADH/FADH2 is captured as ATP; the rest is released as heat or used to maintain pmf.

  • Energy accounting and efficiency (summary from the notes)

    • NADH-linked energy: ~35% of the energy released from NADH is captured as ATP (≈ 2.5 ATP per NADH; ~77.5 kJ per NADH).

    • FADH2-linked energy: ~31% of the energy released from FADH2 is captured as ATP (≈ 1.5 ATP per FADH2; ~46.5 kJ per FADH2).

    • The remainder is lost as heat due to imperfect coupling between electron transport and ATP synthesis.

  • Net ATP yield from glucose (classic accounting in this course)

    • Glycolysis: 2 ATP (substrate-level) and 2 NADH → ~5 ATP total.

    • PDH: 2 NADH → ~5 ATP.

    • TCA cycle: 2 GTP (ATP) + 6 NADH + 2 FADH2 → ~20 ATP from reduced cofactors (per glucose: 10 NADH → 25 ATP; 2 FADH2 → 3 ATP; plus 2 ATP from GTP).

    • TOTAL ≈ 32 ATP per glucose molecule.

    • Expressed as a sum: \text{Total ATP per glucose} \ = 2 \,(\text{Glycolysis ATP}) + 2 \,(\text{GTP from TCA}) + 10 \,(\text{NADH}) \times 2.5 + 2 \,(\text{FADH2}) \times 1.5 = 32 \,\text{ATP}

  • Efficiency and tissue variation

    • Oxidative phosphorylation is highly efficient but can vary with tissue type.

    • Brown adipose tissue (BAT) engages extra heat generation via uncoupling.

Substrate-Level vs Oxidative Phosphorylation: Key distinctions
  • Oxidative phosphorylation

    • Produces ATP from ADP and Pi using energy from a proton gradient created by ETC.

    • Requires membrane-associated complexes (inner mitochondrial membrane).

    • Energy coupling occurs via pmf; most energy conserved as ATP, some lost as heat depending on coupling efficiency.

    • Oxygen is required (final electron acceptor).

  • Substrate-level phosphorylation

    • Produces ATP directly from a substrate without a proton gradient or membrane-bound ATP synthase.

    • Occurs in cytosol and mitochondrial matrix (glycolysis and TCA step(s)).

    • Can occur in absence of oxygen (to a limited extent).

  • Comparative efficiency

    • Oxidative phosphorylation: higher overall ATP yield but variable efficiency depending on coupling; significant heat production when uncoupled.

    • Substrate-level phosphorylation: direct ATP production but lower overall energy yield per substrate.

Uncoupling and Heat Production
  • Uncoupling concept

    • Uncouplers increase inner mitochondrial membrane permeability to protons, dissipating the pmf and eliminating the drive for ATP synthesis.

    • Heat is generated instead of ATP production; can be lethal if uncontrolled.

  • Synthetic uncouplers

    • Dinitrophenol (DNP) and dinitrocresol (DNC) are classic examples.

    • Result: proton gradient collapses; ATP synthesis declines; heat production rises.

  • Natural uncoupling: UCP1 (thermogenin) in brown adipose tissue (BAT)

    • Activated by cold exposure and noradrenaline (norepinephrine).

    • Process:
      1) Lipolysis of triglycerides → fatty acids.
      2) Fatty acids provide reducing power for oxidative phosphorylation and activate UCP1.
      3) UCP1 shuttles protons from intermembrane space to matrix, bypassing ATP synthase.

    • Consequence: electron transport proceeds, but ATP production is uncoupled from the proton gradient; energy released as heat (non-shivering thermogenesis).

  • Physiological relevance

    • BAT thermogenesis contributes to heat generation in cold environments.

    • Uncoupling serves as a mechanism for heat production in humans and some mammals.

Oxidative Phosphorylation: Clinical and Pathophysiological Aspects
  • Tight coupling is essential for efficient ATP production

    • When coupling is disrupted, energy supply becomes compromised; cells may rely more on glycolysis and produce lactate (anaerobic metabolism) under some conditions.

  • Oxidative phosphorylation diseases (mtDNA and nuclear DNA mutations involved)

    • Leber hereditary optic neuropathy (LHON): mutations in complex I subunit genes; presents with progressive vision loss.

    • Leigh syndrome: mutations in genes encoding components of the ATP synthase or other ETC components; presents with neurodegeneration and psychomotor decline in infancy.

    • MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes): mtDNA mutations affecting energy production; heterogeneous clinical presentation.

Energy Balance and Head-to-Head: Glucose Catabolism in Numbers
  • Overall oxidation of glucose to CO2 and H2O (theoretical \Delta G^\theta)

    • \text{C}6 \text{H}{12} \text{O}6 + 6 \text{O}2 \ ightarrow 6 \text{CO}2 + 6 \text{H}2 \text{O}

    • \Delta G^\theta_\text{overall (glucose oxidation)} \ = -2870\text{ kJ/mol}

  • Energy accounted so far (substrate-level phosphorylation)

    • Glycolysis: 2 ATP net (4 ATP produced; net = 2 ATP) and 2 NADH → ~5 ATP.

    • PDH: 2 NADH → ~5 ATP.

    • TCA cycle: 2 GTP (ATP) and 6 NADH + 2 FADH2 → ~20 ATP from reduced cofactors.

    • Substrate-level phosphorylation total: ~4 ATP (glycolysis + TCA) => cited as ~-124 kJ/mol energy.

  • Rest of energy is stored in reduced cofactors for oxidative phosphorylation

    • Remaining energy after substrate-level phosphorylation: approximately -2746 kJ/mol stored in NADH + H+ and FADH2.

  • Net ATP yield summary (glucose -> 32 ATP in this model)

    • NADH: 10 total from glycolysis, PDH, and TCA → 10 × 2.5 = 25 ATP.

    • FADH2: 2 total → 2 × 1.5 = 3 ATP.

    • LTP: 4 ATP.

    • Total: 25 + 3 + 4 = 32 ATP per glucose molecule.

  • Expression of ATP yields (summary form)

    • \text{ATP}{\text{NADH}} = 2.5 \times n{\text{NADH}}

    • \text{ATP}{\text{FADH}2} = 1.5 \times n{\text{FADH}2}

    • \text{Total ATP} = 32 \text{ per glucose} \ (\text{in this framework})

Biosynthetic Roles of TCA Intermediates
  • TCA intermediates provide carbon skeletons for multiple biosynthetic pathways

    • Citrate is a precursor for fatty acids and sterols (via acetyl-CoA) and for other biosynthetic routes.

    • α-Ketoglutarate is a precursor to several amino acids via transamination.

    • Succinyl-CoA is a precursor for heme synthesis.

    • Oxaloacetate can feed gluconeogenesis (in liver) and amino acid synthesis.

    • Malate and oxaloacetate also participate in shuttle systems (malate–aspartate shuttle) and replenishment (anaplerotic reactions).

Connections to Foundational Principles and Real-World Relevance
  • Centrality of mitochondria in energy metabolism

    • Oxidative metabolism sits at the heart of energy production, integrating carbohydrate, fat, and protein catabolism.

  • Regulation integrates energy status signals

    • NAD+/NADH, ADP/ATP ratios, allosteric modulators, and hormonal signals (e.g., insulin effects on PDH via phosphatases).

  • Pathophysiology in energy disorders

    • PDH deficiency and mtDNA mutations illustrate how energy failure manifests in neurological and muscular symptoms; mitochondrial diseases can be inherited and have multisystem effects.

  • Pharmacological and nutritional implications

    • Ketogenic diets for PDH deficiency; understanding uncoupling informs metabolic heat production and potential therapeutic strategies (e.g., thermogenesis).

Key Equations and Expressions (LaTeX)
  • PDH-catalysed reaction

    • \text{pyruvate} + \text{CoA} + \text{NAD}^+ \ ightarrow \text{acetyl–CoA} + \text{CO}_2 + \text{NADH} + \text{H}^+

  • TCA cycle (one acetyl-CoA turn)

    • \text{CH}3 \text{CO–S–CoA} + 3 \text{NAD}^+ + \text{FAD} + \text{GDP} + \text{P}i + 2 \text{H}2 \text{O} \ ightarrow 2 \text{CO}2 + \text{CoA} + 3 \text{NADH}^+ + \text{H}^+ + \text{FADH}_2 + \text{GTP}

  • ATP yield from NADH and FADH2 (discrete yields)

    • \text{ATP per NADH} = 2.5 \text{ ATP per FADH}_2 = 1.5

  • Total ATP from glucose (summary)

    • \text{Total ATP per glucose} = 2 \ (\text{glycolysis}) + 2 \ (\text{GTP from TCA}) + 10 \times 2.5 \ + 2 \times 1.5 = 32 \text{ ATP}

  • Proton motive force (pmf) across the inner mitochondrial membrane

    • \text{pmf} = \ \Delta \psi - \frac{RT}{F} \ln \bigg( \frac{[\text{H}^+]{\text{in}}}{[\text{H}^+]{\text{out}}} \bigg)

  • Overall oxidative phosphorylation (conceptual)

    • Energy from pmf drives ATP synthesis via ATP synthase (F1F0-ATPase): \text{ADP} + \text{P}_i \xrightarrow{\text{ATPsynthase}} \text{ATP}

  • Energy of glucose oxidation (thermodynamics)

    • \Delta G^\theta_\text{overall} \,=\,-2870\ \text{kJ/mol}

Short note on terminology
  • Oxidative phosphorylation vs substrate-level phosphorylation

    • Oxidative phosphorylation depends on a proton gradient and membrane-bound enzyme complexes.

    • Substrate-level phosphorylation transfers a phosphate to ADP directly from a high-energy substrate, without a gradient.

Quick literature pointers (conceptual, not exhaustive)
  • PDH deficiency and ketogenic diet as therapeutic approach

  • LHON, Leigh syndrome, MELAS as illustrative oxidative phosphorylation diseases

  • UCP1 in brown adipose tissue and non-shivering thermogenesis as a physiological uncoupling mechanism

Connections to prior and subsequent topics
  • Links to glycolysis

    • NAD+/NADH balance, lactate production under redox stress.

  • Anticipated discussion

    • Metabolic regulation in fasting/feeding states and energy demand variations.

  • Foundations for exploring

    • Metabolic diseases and pharmacological targets in energy metabolism.